Blog
FDA Publishes Guidance Snapshot on Conducting Clinical Trials with Decentralized Elements
A decentralized clinical trial (DCT) includes clinical trials where trial-related activities occur at locations other than traditional clinical trial sites such as hospitals and clinics. The Food and Drug Administration (FDA) published a Guidance Snapshot on Friday, October 17, 2025, which highlights elements from a full FDA guidance document for companies conducting DCTs….
By: Stinson LLP